Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could cancer trick the body into attacking its own platelets?

NCT ID NCT06444477

Completed Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 33 adults who had both immune thrombocytopenia (ITP) — a condition where the immune system destroys platelets — and cancer. Researchers wanted to see if treating the cancer could also improve ITP. They also investigated whether cancer cells might mimic platelets, triggering the immune attack. The goal is to better understand this connection and improve care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could clarify why some cancer patients develop low platelet counts and point toward better management strategies.
What could go wrong
This is a small, completed observational study (33 participants) with no intervention tested. Results may not apply to all cancer types or ITP patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune thrombocytopenic purpura cancer neoplasm Purpura, Thrombocytopenic, Idiopathic thrombocytopenia due to immune destruction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER IMMUNE THROMBOCYTOPENIA IMMUNE THROMBOCYTOPENIC PURPURA NEOPLASMS

Contacts and locations

Locations

  • AP-HM Hôpital la Timone - service de médecine interne

    Marseille, France

  • AP-HP Hôpital Bichat service de médecine interne

    Paris, France

  • AP-HP Hôpital Bicêtre service de médecine interne

    Le Kremlin-Bicêtre, France

  • AP-HP Hôpital Jean Verdier service de médecine interne

    Bondy, France

  • AP-HP Hôpital Mondor service de médecine interne

    Créteil, France

  • AP-HP Hôpital Saint-Antoine service de médecine interne

    Paris, France

  • AP-HP Hôpital Saint-Louis service immuno-hématologie

    Paris, France

  • CHRU d'Orléans - service de Médecine interne

    Orléans, France

  • CHRU d'Orléans - service de réanimation

    Orléans, France

  • CHRU de Nancy - service de Médecine Interne et Immunologie Clinique

    Nancy, France

  • CHRU de Strasbourg - service de médecine interne

    Strasbourg, France

  • CHU de Bordeaux Service de Médecine Interne et Maladies Infectieuses

    Pessac, France

  • CHU de Clermont-Ferrand - service de médecine interne

    Clermont-Ferrand, France

  • CHU de Lille - service d'Hématologie

    Lille, France

  • CHU de Montpellier - service d'Hématologie

    Montpellier, France

  • CHU de Nantes - service de médecine interne

    Nantes, France

  • CHU de Poitiers - service de médecine interne

    Poitiers, France

  • CHU de Toulouse - service de médecine interne

    Toulouse, France

  • CHU de Tours - service de médecine interne

    Tours, France

  • HCL - service d'Hématologie

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.